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Background
The use of antiretroviral drug therapies in HIV-1 infected
pregnant women and their infants has resulted in signifi-
cant reductions in the rates of mother-to-child transmis-
sion (MTCT), although emerging resistances become a
growing concern. The aim of this study was to characterize
resistance patterns of HIV-1 strains for mother-infant
pairs among the residual cases of vertical transmission.
Materials and methods
HIV-1 infected infants by vertical transmission diagnosed
in their first year of life in a single teaching hospital and
born between January 1997 and May 2006 were enrolled.
Viral genotypes were performed on available samples of
plasma RNA-HIV, at the time of diagnosis for infants and
the closest possible to delivery in their respective mothers.
HIV-1 genotype drug resistance interpretation was based
on the ANRS algorithm of July 2006. Whenever possible,
genotypic drug resistance profile of HIV-1 was also
obtained for the father.
Results
18 mother-infant pairs were included, 11 identified
through MTCT prevention follow-up (MTCT rate: 11/
947=1.2%), 7 cases in various contexts with mothers diag-
nosed for HIV-1 beyond delivery. Samples were available
for genotypes in 14 of them. In 4/14 (29%) infected HIV-
1 newborns, resistant virus to at least one antiretroviral
drug were observed. For these four cases, two genotypic
analyses of the father supplemented the analysis of muta-
tion transmission.
In the first mother-infant pair, mutation M184V/M was
identified in the sample of the newborn (unexposed post-
natally to 3TC) at 14 days of life although not detected in
its mother's sample at 40 days before delivery. In the sec-
ond mother-infant pair, poor compliance of multitreated
woman explained vertical transmission of multidrug-
resistant HIV-1 (AZT, 3TC and IP). In the third case, iden-
tical mutations conferring resistance to AZT (T215Y) and
NNRTI (K103N+Y181V) were observed in the infant and
both parents. The last case resulted from a documented
primary HIV-1 infection in late pregnancy with vertical
transmission of a K101E resistant mutation isolated also
in father and mother, both being naïve to ARVs.
Conclusions
Over almost 10 years, 18 cases of vertical transmission of
HIV-1 were registered in this cohort with an important
proportion of infected infants who acquired drug-resist-
ant virus (4/14 – 29%). The results of this study raise the
importance of HIV screening of pregnant women and
partners. Viral genotyping can guide prophylaxis regimen
and/or treatment of infected infants.
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